Enhancement of the Human Immunodeficiency Virus (HIV) specific cytotoxic T-cells mechanisms in an HIV-1 and Mycobacterium tuberculosis (Mtb) co-infected individual seems to improve the clinical picture of an individual by reducing Acquired Immuno Deficiency Syndrome (AIDS) state progression rate. In this paper, we develop a system of deterministic differential equations representing the immune cells involved in an HIV-1 and Mtb co-infected individual. Results show that although the non-lytic arm of the HIV-1 cytotoxic T-cells affects the co-infection dynamics more than the lytic factors, a combination of both factors results in a more positive reduced progression to the AIDS state. This is due to the increased protection of the CD4+ T-cells by the CTL mechanisms by further reducing infections and replications by the HIV. Thus, HIV-1 specific CTLs mechanisms’ involvement is here recommended to be part of a solution to the HIV and Mtb co-infection problems.
References
[1]
Shankarkumar, U. and Shankarkumar, A. (2011) Role of HLA-A, HLA-B, HLA-DRB1 and HLADQB1 Alleles in HIV-1 Patients with Pulmonary Tuberculosis Co-Infection from Western India. World Journal of AIDS, 1, 136-138. https://doi.org/10.4236/wja.2011.14019
[2]
Dye, C., Scheele, S., Dolin, P., Pathania, V. and Raviglione, M.C. (1999) Consensus Statement. Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country. WHO Global Surveillance and Monitoring Project. JAMA, 282, 677-686.
https://doi.org/10.1001/jama.282.7.677
[3]
Selwyn, P.A., Hartel, D., Lewis, V.A., Schoenbaum, E.E., Vermund, S.H., et al. (1989) A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection. New England Journal of Medicine, 320, 545-550.
https://doi.org/10.1056/NEJM198903023200901
[4]
Aaron, L., Saadoun, D., Calatroni, I., Launay O., Memain N., et al. (2004) Tuberculosis in HIV-Infected Patients: A Comprehensive Review. Clinical Microbiology and Infection, 10, 388-398. https://doi.org/10.1111/j.1469-0691.2004.00758.x
[5]
Spear, G.T., Kessler, H.A., Rothberg, L., Phair, J. and Landay, A.L. (1990) Decreased Oxidative Burst Activity of Monocytes from Asymptomatic HIV-Infected Individuals. Clinical Immunology and Immunopathology, 54, 184-191.
https://doi.org/10.1016/0090-1229(90)90080-A
[6]
Wahl, S.M., Allen, J.B., Gartner, S., Orenstein, J.M., Popovic M., et al. (1989) HIV-1 and Its Envelope Glycoprotein Down-Regulate Chemotactic Ligand Receptors and Chemotactic Function of Peripheral Blood Monocytes. Journal of Immunology, 142, 3553-3559.
[7]
Havlir, D.V. and Barnes, P.F. (1999) Tuberculosis in Patients with Human Immunodeficiency Virus Infection. New England Journal of Medicine, 340, 367-373.
https://doi.org/10.1056/NEJM199902043400507
[8]
Patel, N.R., Zhu, J., Tachado, S.D., Zhang, J. and Wan, Z. (2007) HIV Impairs TNF-Alpha Mediated Macrophage Apoptotic Response to Mycobacterium tuberculosis. Journal of Immunology, 179, 6973-6980. https://doi.org/10.4049/jimmunol.179.10.6973
[9]
Diedrich, C.R. and Flynn, J.L. (2011) HIV-1/Mycobacterium tuberculosis Co-Infection Immunology: How Does HIV-1 Exacerbate Tuberculosis? Infection and Immunity, 79, 1407-1417. https://doi.org/10.1128/IAI.01126-10
[10]
Nakata, K., Rom, W.N., Honda, Y., Condos, R., Kanegasaki, S., et al. (1997) Mycobacterium tuberculosis Enhances Human Immunodeficiency Virus-1 Replication in the Lung. American Journal of Respiratory and Critical Care Medicine, 155, 996-1003.
https://doi.org/10.1164/ajrccm.155.3.9117038
[11]
Shattock, R.J., Friedland, J.S. and Griffin, G.E. (1993) Modulation of HIV Transcription in and Release from Human Monocytic Cells Following Phagocytosis of Mycobacterium tuberculosis. Research in Virology, 144, 7-12. https://doi.org/10.1016/S0923-2516(06)80005-1
[12]
Zhang, Y., Nakata, K., Weiden, M. and Rom, W.N. (1995) Mycobacterium Tuberculosis Enhances Human Immunodeficiency Virus-1 Replication by Transcriptional Activation at the Long Terminal Repeat. Journal of Clinical Investigation, 95, 2324-2331.
https://doi.org/10.1172/JCI117924
[13]
Orenstein, J.M., Fox, C. and Wahl, S.M. (1997) Macrophages as a Source of HIV during Opportunistic Infections. Science, 276, 1857-1861.
https://doi.org/10.1126/science.276.5320.1857
[14]
Mancino, G., Placido, R., Bach, S., Mariani, F., Montesano, C., et al. (1997) Infection of Human Monocytes with Mycobacterium Tuberculosis Enhances Human Immunodeficiency Virus Type 1 Replication and Transmission to T-Cells. Journal of Infectious Diseases, 175, 1531-1535. https://doi.org/10.1086/516494
[15]
Ignatowicz, L., Mazurek J., Leepiyasakulchai, C., Skold, M., Hinkula, J., et al. (2012) Mycobacterium Tuberculosis Infection Interferes with HIV Vaccination in Mice. PLoS ONE, 7, e41205. https://doi.org/10.1371/journal.pone.0041205
[16]
Pawlowski, A., Jansson, M., Skold, M, Rottenberg, M.E. and Kallenius, G. (2012) Tuberculosis and HIV Co-Infection. PLOS Pathogens, 8, e1002464.
https://doi.org/10.1371/journal.ppat.1002464
[17]
Khan, F.A., Minion, F., Pai, M., Royce, S., Burman, W., Harries, A.D. and Menzies, D. (2010) Treatment of Active Tuberculosis in HIV-Co-Infected Patients: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases, 50, 1288-1299.
https://doi.org/10.1086/651686
[18]
Ramkissoon, S., Mwambi, H.G. and Matthews, A.P. (2012) Modelling HIV and MTB Co-Infection including Combined Treatment Strategies. PLoS ONE, 7, e49492.
https://doi.org/10.1371/journal.pone.0049492
[19]
Sharada, R.M., Rani, H.S., Pydi, S.S., Subbanna, J. and Vallur, V.L. (2012) CD38 Expression on CD8+ Cells—Its Influence on Development of Tuberculosis in HIV Positive Individuals. Open Journal of Immunology, 2, 65-71. https://doi.org/10.4236/oji.2012.22008
[20]
Ogg, G.S., Dunbar, P.R., Rowland-Jones, S.L., Cerundolo, V. and McMichael, V.J. (1998) Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA. Science, 279, 2103-2106. https://doi.org/10.1126/science.279.5359.2103
[21]
Rowland-Jones, S.L., Dong, T., Fowke, K.R., Kimani, J., et al. (1998) Cytotoxic T Cell Responses to Multiple Conserved HIV Epitopes in HIV-Resistant Prostitutes in Nairobi. Journal of Clinical Investigation, 102, 1758-1765. https://doi.org/10.1172/JCI4314
[22]
Kirshner, D. (1999) Dynamics of Co-Infection with M. Tuberculosis and HIV-1. Theoretical Population Biology, 55, 94-109. https://doi.org/10.1006/tpbi.1998.1382
[23]
Ganusov, V.V. (2003) The Role of the CTL Response and Virus Cytopathogenecity in the Virus Decline during Antiviral Therapy. Proceedings of the Royal Society of London B, 270, 1513-1518. https://doi.org/10.1098/rspb.2003.2401
[24]
Ernst, W.A., Thoma-Uszynski, S., Teitelbaum, R., Ko, C., Hanson, D.A., Clayberger C., Krensky, A.M., Leippe, M., Bloom, B.R., Ganz, T., et al. (2000) Granulysin, a T Cell Product, Kills Bacteria by Altering Membrane Permeability. Journal of Immunology, 165, 7102-7108. https://doi.org/10.4049/jimmunol.165.12.7102
[25]
Klenerman, P., Wu, P. and Phillips, R. (2002) HIV: Current Opinion on Escapology. Current Opinion on Microbiology, 5, 28-36. https://doi.org/10.1016/S1369-5274(02)00339-9
[26]
Magombedze, G., Garira, W. and Mwenje, W.E. (2006) Mathematical Models of Chemotherapy of Human Tuberculosis Infection. Biological Sciences, 14, 509-553.
[27]
Garira, W., Hove-Musekwa, S.D. and Shiri, T. (2005) Optimal Control of Combined Therapy in a Single Strain HIV-1 Model Electronic. Journal of Differential Equations, 52, 1-22.
[28]
Wodarz, D., LLyod, A.L., Jansen, V.A.A. and Nowak, M.A. (1999) Dynamics of Macrophages and T Cell Infection by HIV. Journal of Theoretical Biology, 196, 101-113.
https://doi.org/10.1006/jtbi.1998.0816
[29]
Wodarz, D. and Nowak, M.A. (2000) Immune Responses and Viral Phenotype:do Replication Rate and Cytopathogenecity Influence Virus load? Journal of Theoratical Medicine, 2, 113-117. https://doi.org/10.1080/10273660008833041
[30]
Driessche, V.P. and Watmough, J. (2002) Reproduction Numbers and Sub-Threshold Endemic Equilibria for Compartmental Models of Disease Transmission. Mathematical Biosciences, 180, 29-48. https://doi.org/10.1016/S0025-5564(02)00108-6
[31]
Mufudza C. (2008) Analaysing the Effects of Cytotoxic T-Cells in the HIV-1 and Myco-Bacterium Tuberculosis Co-Infection. Msc Thesis, University of Zimbabwe, Harare, 1-95.
